Drusolv Therapeutics
Drusolv Therapeutics is a clinical-stage drug company focused on development of a novel, high-dose statin for early intervention in a blinding eye disease called age-related macular degeneration (AMD)...load more
Drusolv Therapeutics's Basic Information
Industry
Pharmaceutical Manufacturing
Headquarters
Philadelphia, Pennsylvania, United States
Website
Founded Year
2017
Headcount
2 - 10 ( View All )
Drusolv Therapeutics's Competitors
PIERRE GUERIN
View all employeesAmoli International
View all employeesStudio CEO Salon & SPA
View all employeesEmployee Insights
Drusolv Therapeutics's Top Employees
John Edwards
Founder AND Chief Executive Officer
Phone Email
Frequently Asked Questions Regarding Drusolv Therapeutics
Connect with anyone with AroundDeal today!
Whether you're looking to connect with key decision-makers or making remote or global hires, we've got you covered.
✔ GDPR aligned & CCPA compliant✔ Cancel anytime✔ 5 free contacts